Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × INCB039110 × Clear all

NCT02917993 2026-02-09

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Inhibition, Psychological, Lung Neoplasms, Neoplasm Metastasis

NCT03425006 2023-09-13

Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer

Phase 2 Terminated

23 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung